Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epithelial Mesenchymal Transition”

49 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 49 results

Not applicableUnknownNCT05403164
What this trial is testing

Epithelial Mesenchymal Transition and Periodontitis

Who this might be right for
PeriodontitisPeriodontal DiseasesEpithelial-Mesenchymal Transition+3 more
University of Baghdad 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT04077099
What this trial is testing

REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer

Who this might be right for
NSCLC
Regeneron Pharmaceuticals 95
Early research (Phase 1)Study completedNCT03030417
What this trial is testing

Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas

Who this might be right for
Solid TumorsLymphoma
National Cancer Institute (NCI) 36
Not applicableUnknownNCT04323917
What this trial is testing

Detection of High Expression Levels of EMT-Transcription Factor mRNAs in Patients With Pancreatic Cancer and Their Diagnostic Potential

Who this might be right for
Pancreatic Cancer
Istituto Clinico Humanitas 850
Not applicableWithdrawnNCT02022904
What this trial is testing

Prostate Cancer Circulating Tumor Cells Based on Epithelial-Mesenchymal Transition Biology

Who this might be right for
Prostate Cancer
Duke University
Not applicableStudy completedNCT06055660
What this trial is testing

Moesin Expression in Clear Cell Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Sohag University 50
Early research (Phase 1)Study completedNCT02412462
What this trial is testing

Phase I Dose Escalation Study of AB-16B5 in Subjects With an Advanced Solid Malignancy

Who this might be right for
Solid TumorMetastatic Cancer
Alethia Biotherapeutics 15
Not applicableNot Yet RecruitingNCT07529639
What this trial is testing

Tumor Budding and T1 Substaging in Urothelial Bladder Cancer

Who this might be right for
Urothelial Bladder CarcinomaBladder CarcinomaNon-Muscle-Invasive Bladder Cancer (NMIBC)+1 more
Assiut University 100
Not applicableUnknownNCT02940977
What this trial is testing

Establishment and Clinical Assessment of a Prostate Cancer (PCa) Risk Model Based on the Updated Circulating Tumor Cell (CTC) Detection Technique

Who this might be right for
Prostatic NeoplasmsProstatic Adenoma
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 120
Not applicableStudy completedNCT03732872
What this trial is testing

Epithelial Mesenchymal Transition Markers in OSMF

Who this might be right for
Oral Submucous Fibrosis
The Oxford Dental College, Hospital and Research Center, Bangalore, India 185
Testing effectiveness (Phase 2)Ended earlyNCT04926831
What this trial is testing

Phase II of Neoadjuvant and Adjuvant Capmatinib in NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Novartis Pharmaceuticals 4
Early research (Phase 1)Active Not RecruitingNCT02609776
What this trial is testing

Study of Amivantamab, a Human Bispecific EGFR and cMet Antibody, in Participants With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Cancer
Janssen Research & Development, LLC 751
Not applicableUnknownNCT04137406
What this trial is testing

Role of SIRT1 in Regulation of Epithelial-to-mesenchymal Transition in Breast Cancer Lymph Nodes Metastasis

Who this might be right for
Breast CancerLymph Node Metastases
Peking University People's Hospital 160
Not applicableStudy completedNCT04817501
What this trial is testing

Phenotypic Spectrum of CTCs in Tumors of the Female Reproductive System

Who this might be right for
Breast CancerOvarian CancerEndometrial Cancer
Tomsk National Research Medical Center of the Russian Academy of Sciences 150
Early research (Phase 1)Ended earlyNCT01441128
What this trial is testing

-02341066 and PF-00299804 for Advanced Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell LungAdenocarcinomaCarcinoma, Squamous Cell+1 more
National Cancer Institute (NCI) 20
Not applicableUnknownNCT01927354
What this trial is testing

Study on the Interplay Between Twist1 and Other EMT Regulators Through microRNA-29 Family.

Who this might be right for
Head-and-Neck Squamous Cell Carcinoma
National Taiwan University Hospital 100
Large-scale testing (Phase 3)Study completedNCT01079143
What this trial is testing

Progression of Renal Interstitial Fibrosis / Tubular Atrophy (IF/TA) According to Epithelial-mesenchymal Transition (EMT) and Immunosuppressive Regimen (Everolimus Based Versus CNI Based) in de Novo Renal Transplant Recipients

Who this might be right for
Renal Interstitial Fibrosis
Novartis Pharmaceuticals 194
Not applicableUnknownNCT03381326
What this trial is testing

CTC, Free DNA, Stem Cells and EMT-related Antigens as Biomarkers of Activity of Cabazitaxel in CRPC.

Who this might be right for
Prostate CancerMetastatic CancerCastration-resistant Prostate Cancer+1 more
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 104
Early research (Phase 1)Study completedNCT02221882
What this trial is testing

LY3164530 in Participants With Cancer

Who this might be right for
NeoplasmsNeoplasm Metastasis
Eli Lilly and Company 29
Large-scale testing (Phase 3)Looking for participantsNCT06417008
What this trial is testing

HS-20117 Combined With Aumolertinib in Participants With Advanced Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hansoh BioMedical R&D Company 1,080
Next Page